[Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka
M M
MM
Service de Médecine Interne I, CHU A. Le Dantec, Dakar.
Ndiaye
M F
MF
Herve
P
P
Legueno
B
B
Diop
B M
BM
Dangou
J M
JM
Niang
A
A
Woto-Gaye
G
G
Mendes
V
V
Diop
T M
TM
Ndiaye
P D
PD
Bao
O
O
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000821:virology*; D016022:Case-Control Studies; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D012675:Senegal / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D014505:Urban Population
D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D018937:Hepatitis C Antibodies